Hepatitis C Virus (HCV) Infection Completed Phase 2 / 3 Trials for Danoprevir (DB11779)

Also known as: Hepatitis C (HCV) / HCV Infection / HCV Infections / HCV / Hepatits C / Hepatitis C Virus (HCV) / Hepatitis C Virus / Hepatitis C virus test

IndicationStatusPhase
DBCOND0052122 (Hepatitis C Virus (HCV) Infection)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03362814Efficacy and Safety of Ravidasvir in Combination With Danoprevir/r and Ribavirin(RBV) in Treatment-naive, Non-cirrhotic, Chronic Hepatitis C Virus Genotype1 Infected Subjects.Treatment